Trastuzumab

Term: TrastuzumabDefinition: Trastuzumab is a monoclonal antibody used in the treatment of certain cancers, including lung cancer, which can be linked to asbestos exposure.Phonetic Pronunciation: (tra-stoo-ZOO-mab)Origin: The term 'Trastuzumab' originates from a combination of 'tras-', derived from 'trans-', indicating across or beyond, and '-tuzumab', a suffix used for monoclonal antibodies. This naming convention follows the guidelines set by the World Health Organization for biopharmaceutical nomenclature, reflecting the drug's mechanism and type.Significance in Asbestos Context: Trastuzumab is significant in the context of asbestos-related diseases because it can be used to treat lung cancers that may develop due to asbestos exposure. Its targeted therapy approach can improve outcomes for patients suffering from asbestos-induced malignancies.Example Sentence: "Following his diagnosis of lung cancer linked to asbestos exposure, the patient began a course of treatment with Trastuzumab to target the cancer cells specifically."Related Terms: Monoclonal antibody, lung cancer, targeted therapy, chemotherapy, immunotherapy.Notes: - Trastuzumab is not a cure but can significantly improve quality of life and survival rates. - It is often used in combination with other treatments. - Side effects can include heart problems, so monitoring is essential. - Trastuzumab may not be effective for all types of lung cancer associated with asbestos exposure.